Medication info

Olmatan Tablet 20mg (Olmesartan Medoxomil)

Prescription medicationTabletOralExpired
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tablet
Manufacturer / importer
Aprogen BioLogics Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201906574 · Approved 2019.09.19

This product's status changed to Expired on 2024.09.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased up to a maximum of 40mg per day. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while carefully monitoring their condition. <Older adults> No dose adjustment is necessary when administering this medicine to older adults aged 65 years or older. No overall differences in efficacy or safety have been observed between older and younger patients; however, the possibility of a more sensitive response in some older adults cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose in patients with moderate hepatic impairment is 10mg once daily, which may be increased up to a maximum of 20mg per day. Use is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.
Child dose
Safety and efficacy have not been established in pediatric patients.

Ingredients

Manufacturer
Aprogen BioLogics Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension refers to a condition where blood pressure remains consistently high, which can affect cardiovascular health in the long term. This medication helps lower blood pressure by either dilating blood vessels or decreasing the workload on the heart. By consistently taking this medication, blood pressure can be managed stably, and the occurrence of complications can be prevented. Therefore, it is effectively used for the treatment of essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased up to a maximum of 40mg per day. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while carefully monitoring their condition. <Older adults> No dose adjustment is necessary when administering this medicine to older adults aged 65 years or older. No overall differences in efficacy or safety have been observed between older and younger patients; however, the possibility of a more sensitive response in some older adults cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose in patients with moderate hepatic impairment is 10mg once daily, which may be increased up to a maximum of 20mg per day. Use is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.

Child dose

Safety and efficacy have not been established in pediatric patients.

Precautions

This drug can cause severe harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it must be stopped immediately upon confirmation of pregnancy. Patients who are allergic to any components of this drug, pregnant or nursing, undergoing kidney dialysis, have severe liver impairment, biliary obstruction, or are lactose intolerant should not take this medication. Patients with reduced blood volume or salt levels may experience hypotension, so their condition should be thoroughly checked before starting treatment. Patients with impaired kidney function, kidney transplant recipients, patients with renovascular hypertension, or those at risk of hyperkalemia should use this medication cautiously, and renal function and electrolyte levels should be checked regularly through blood tests. Particular caution is required for patients with aortic stenosis, mitral valve stenosis, or obstructive heart disease when taking this medication. Since this drug can lower blood pressure and may cause dizziness, caution should be exercised while operating dangerous machinery or driving. Common mild side effects may include dizziness, headache, back pain, and bronchitis, while rare side effects such as liver function abnormalities or angioedema may occur. If symptoms such as chronic diarrhea or significant weight loss appear, it is advised to discontinue use of this drug and consult a physician. Caution is necessary when taken with potassium-sparing diuretics or potassium supplements, as blood potassium levels may increase. When used with lithium, the concentration of lithium may rise and become toxic, so co-administration is not recommended. Pregnant women should avoid this medication to protect fetal health, and nursing mothers should consider discontinuation of either the drug or breastfeeding due to potential adverse reactions in the infant. Safety in pediatric patients has not been established, and it is recommended to avoid use in children. Elderly patients may experience increased drug concentration in their bodies, so dose adjustments and caution are required. In cases of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur, and medical intervention should be sought immediately if they arise.

Side effects

  • Dizziness
  • back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 39 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • asthenia
  • angioedema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • elevated serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • positional vertigo
  • palpitations
  • hypertension
  • epistaxis
  • upper respiratory infection
  • asthma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. A cool place with a temperature between 1 and 25 degrees Celsius is suitable for storage.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.